IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

BALDINI, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 23.059
NA - Nord America 9.805
AS - Asia 6.750
SA - Sud America 385
OC - Oceania 57
AF - Africa 49
Continente sconosciuto - Info sul continente non disponibili 8
Totale 40.113
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.449
DE - Germania 9.255
GB - Regno Unito 6.171
CN - Cina 3.083
IT - Italia 2.075
SE - Svezia 1.696
SG - Singapore 1.162
RU - Federazione Russa 1.033
TR - Turchia 631
UA - Ucraina 617
IE - Irlanda 574
KR - Corea 555
IN - India 554
FR - Francia 451
FI - Finlandia 422
EU - Europa 377
CA - Canada 327
NL - Olanda 275
VN - Vietnam 195
CO - Colombia 180
BR - Brasile 164
ID - Indonesia 142
HK - Hong Kong 112
JP - Giappone 92
DK - Danimarca 81
PL - Polonia 73
GR - Grecia 57
ES - Italia 55
BE - Belgio 48
AU - Australia 47
CH - Svizzera 41
PH - Filippine 29
RO - Romania 26
TW - Taiwan 25
UZ - Uzbekistan 24
MX - Messico 19
CY - Cipro 17
CZ - Repubblica Ceca 16
IL - Israele 16
PK - Pakistan 15
MY - Malesia 13
AT - Austria 12
IR - Iran 12
TH - Thailandia 12
ZA - Sudafrica 11
CL - Cile 10
EC - Ecuador 10
EG - Egitto 10
IQ - Iraq 10
NO - Norvegia 10
NZ - Nuova Zelanda 10
PE - Perù 10
BG - Bulgaria 9
SA - Arabia Saudita 9
HU - Ungheria 8
PT - Portogallo 8
MA - Marocco 7
AR - Argentina 6
HR - Croazia 6
SC - Seychelles 6
TN - Tunisia 6
AL - Albania 5
BD - Bangladesh 5
MK - Macedonia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AM - Armenia 4
KW - Kuwait 4
KZ - Kazakistan 4
LI - Liechtenstein 4
MD - Moldavia 4
NG - Nigeria 4
OM - Oman 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
BY - Bielorussia 3
LU - Lussemburgo 3
AE - Emirati Arabi Uniti 2
GE - Georgia 2
JO - Giordania 2
KG - Kirghizistan 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
NI - Nicaragua 2
NP - Nepal 2
SI - Slovenia 2
SN - Senegal 2
SV - El Salvador 2
UY - Uruguay 2
AP - ???statistics.table.value.countryCode.AP??? 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BS - Bahamas 1
BZ - Belize 1
CU - Cuba 1
DZ - Algeria 1
EE - Estonia 1
GA - Gabon 1
GT - Guatemala 1
Totale 40.474
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 7.086
Southend 5.781
Chandler 1.156
Seattle 885
Singapore 820
Beijing 762
Milan 738
Princeton 698
Dublin 571
Wilmington 549
Jacksonville 470
Ashburn 360
Redmond 354
Nanjing 341
Mountain View 340
Dearborn 308
Fairfield 293
Ann Arbor 263
Somerville 259
Toronto 256
Sakarya 220
Andover 219
Serra 214
Des Moines 191
Boardman 190
Hangzhou 187
Bengaluru 180
Bogotá 177
Shanghai 165
Houston 162
Woodbridge 161
Santa Clara 160
Helsinki 151
Jinan 143
Munich 132
Berlin 124
Hanover 107
Shenyang 103
Nanchang 97
Guangzhou 96
Kiez 89
Eitensheim 85
Hebei 83
Grafing 81
Dong Ket 75
Hong Kong 75
Tianjin 74
Cambridge 69
Jakarta 69
Changsha 67
Redwood City 67
Phoenix 66
Nürnberg 64
New York 63
Warsaw 57
Saint Petersburg 56
Fuzhou 55
Kunming 54
Jiaxing 51
Seoul 51
Zhengzhou 51
Bitonto 48
San Diego 47
Roxbury 46
Athens 45
Turin 44
Rome 41
Ottawa 40
Hamburg 39
Los Angeles 35
Odernheim 35
Bühl 34
Brussels 33
Hefei 30
Norwalk 30
Sunnyvale 27
Tokyo 27
Ningbo 26
San Jose 26
Wuhan 26
Falls Church 25
Hyderabad 25
Mumbai 24
Pisa 24
Taizhou 24
Istanbul 23
Kent 23
Verona 23
Fremont 21
Haikou 21
Quanzhou 21
Piscataway 19
Rochester 19
São Paulo 19
Costa Mesa 18
Lanzhou 18
Naples 18
Nuremberg 17
Taiyuan 17
Yubileyny 17
Totale 27.966
Salva come PNG Salva come JPEG
Nome #
Clinical-biological characterization of variant B chronic lymphocytic leukemia, characterized by a mantle cell lymphoma-like immunophenotype, t(11;14)(q13;q32) negative 443
Gene expression profiling of plasma cell dyscrasias reveals molecular patterns associated with distinct IGH translocations in multiple myeloma 396
Upfront treatment of mantle cell lymphoma by sequential high dose immunochemotherapy supported by in vivo-purged stem cell double autologous transplantation : a single institution experience 326
ABVD versus modified Stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin lymphoma : final results of a multicenter, randomized trial by the Intergruppo Italiano Linfomi 306
R-chop vs R-mini-chop in elderly patients with diffuse large B-cell lymphoma (B-DLCL) prospectively selected by a multidimensional evalutation scale : preliminary results of a randomized study pc performed by intergruppo italiano linfomi (IIL) 306
Plasmablastic lymphoma of the stomach : a case report 293
Frontline antiviral therapy in a series of HCV-related low grade non-Hodgkin lymphoma 268
Circulating tumor DNA as a liquid biopsy in plasma cell dyscrasias 256
Prognostic scoring system for IGG and IGA monoclonal gammopathies of undetermined significance 251
High dose sequential chemotherapy with autologous transplantation versus dose-dense chemotherapy MegaCEOP as first line treatment in poor-prognosis diffuse large cell lymphoma : an "Intergruppo Italiano Linfomi" randomized trial 247
UGT1A1 genotype does not affect tyrosine kinase inhibitors efficacy and safety in chronic myeloid leukemia 247
Clinical features of non Hodgkin's lymphomas associated with hepatitis C virus infection : study of the 'Registro lombardo dei linfomi HCV-positivi' (Lombardy Registry of HCV-positive lymphomas, Italy) 246
Identification of specific transcriptional patterns associated with hyperdiploidy in multiple myeloma 241
A compendium of DIS3 mutations and associated transcriptional signatures in plasma cell dyscrasias 238
Stereotyped patterns of B-CELL receptor in splenic marginal zone lymphoma 236
Prevalence of ras gene mutations in the context of a molecular classification of multiple myeloma 235
Post-transplant lymphoproliferative disorders in liver and kidney recipients : a single institution experience 235
Analisi del numero di copie e sequenza del DNA in campioni sequenziali di melanoma alla diagnosi e recidiva=DNA copy number and whole-exome sequencing analyses in sequential myeloma samples at diagnosis and relapse 230
Indolent B-cell lymphomas treated upfront with antiviral therapy : a series of 13 patients 222
Diagnostic role and prognostic significance of a simplified immunophenotypic classification of mature B cell chronic lymphoid leukemias 221
Ensuring continuity of care of hematologic patients during COVID-19 pandemic in a tertiary hospital in Lombardy (Italy) 217
Molecular events underlying interleukin-6 independence in a subclone of the CMA-03 multiple myeloma cell line 204
Fludarabine, cyclophosphamide and rituximab in patients with advanced untreated indolent B-cell non-follicular lymphomas : final result of phase two study of Fondazione Italiana Linfomi (FIL) 203
Gene Expression Profiling of Plasma Cell Dyscrasias Reveals Molecular Heterogeneity of Multiple Myeloma 202
Molecular spectrum of TP53 mutations in plasma cell dyscrasias by next generation sequencing: an Italian cohort study and overview of the literature 202
Gene expression profiling of multiple myeloma : implications for a molecular classification of the disease 198
Prevalence of ras gene mutations in the context of a molecular classification of multiple myeloma 196
Array-CGH in diffuse large B-cell lymphomas (DLBCL) treated with R-chop identifies recurrent 11Q24.3 aberrations 196
Retrospective analysis of salvage regimen for relapsed or refractory classical Hodgkin lymphoma 196
Molecular spectrum of BRAF, NRAS and KRAS gene mutations in plasma cell dyscrasias : implication for MEK-ERK pathway activation 196
Molecular and transcriptional characterization of 17P loss in B-cell chronic lymphocytic leukemia 195
Analysis of Stereotyped IGHV distribution in a series of 1133 chronic lymphocytic leukemia patients : the experience of a multicenter Italian Study Group 195
Array-CGH identifies regions, including the FOXP1 Locus, associated with different clinical outcome in diffuse large B-cell lymphomas (DLBCL) treated with R-CHOP 194
Molecular Classification of Multiple Myeloma : A Distinct Transcriptional Profile Characterizes Patients Expressing CCND1 and Negative for 14q32 Translocations 193
Front-line chemo-immunotherapy rituximab-FC + rituximab maintenance in patients with untreated adevanced stage non follicular lymphoma (INFL) : preliminary results of a prospective study of the Intergruppo Italiano Linfomi and Roche (ML18324) 192
Diagnostic Role of Flow Cytometry Analysis of Bioptical Samples in the Diagnosis of Lymphoid Tumors 191
11Q13 polisomy and absence of IGH translocations and chromosome 13Q14 deletion characterize a distinct subgroup of multiple myeloma patients expressing CCND 190
Enoxaparin, aspirin, or warfarin for thromboprophilaxis in newly diagnosed myeloma patients receiving thalidomide : a randomized controlled trial 189
Frontline treatment with the combination fludarabine-cyclophosphamide in low-grade non-follicular non-Hodgkin lymphoma : a long term updating of GISL LL02 trial 188
Phase II fludarabine and cyclophosphamide for the treatment of indolent B cell non-follicular lymphomas : final results of the LL02 trial of the Gruppo Italiano per lo Studio dei Linfomi (GISL) 187
Triple-Negative Essential Thrombocythemia: Clinical-Pathological and Molecular Features. A Single-Center Cohort Study 187
Brief chemoimunotherapy with rituximab (R)- Find ± R maintenance as first treatment in adevanced follicular lymphoma (FL) in elderly : preliminary analysis of a prospective randomized trial 183
Brief chemoimmunotherapy rituximab ®-FND +/- R maintenance is effective and safe newly diagnosed follicular lymphoma elderly patients : an intergruppo italiano linfomi (IIL) randomized trial 182
Gruppo Italiano studio linfomi (GISL) Criteria for defining disease-progression in indolent non follicular lymphoma 182
Clinico-biological characterization of a subset of variant B-CLL, defined according to a combined cytofluorimetric/fish diagnostic approach 182
Application of next-generation sequencing for the genomic characterization of patients with smoldering myeloma 182
Outcome prediction of diffuse large B-cell lymphomas associated with hepatitis C virus infection : a study on behalf of the Fondazione italiana linfomi 181
Transcriptional features of 1Q in multiple myeloma 180
Anthracycline-fludarabine containing regimens with or without rituximab in the treatment of advanced follicular lymphoma patients 180
NEAT1 Long Isoform Is Highly Expressed in Chronic Lymphocytic Leukemia Irrespectively of Cytogenetic Groups or Clinical Outcomek 180
Functional impact of genomic complexity on the transcriptome of Multiple Myeloma 180
Lamivudine prophylaxis of hepatitis B reactivation in anti-HBC seroposivive patients undergoing chemotherapy for onco-hematological diseases 178
The cytofluorimetric/FISH diagnostic approach define a B-cell variant-CLL with peculiar clinico-biologic features 176
Reconstruction of transcriptional regulatory networks in multiple myeloma 174
Gene and mirna expression profiles in plasma cell leukemias 174
Granulomatosi di Wegener o linfoma extranodale? 173
Prognostic significance of abdominal CT scan in CLL patients in Binet Stage a : preliminary results of a prospective, multicenter observation –CLL1 - GISL study 173
Brief chemoimmunoterapy rituximab (R)-FND ± R maintenance as first line treatment in elderly patients with advanced follicular lymphoma (FL) : preliminary analysis of a prospective randomized IIL trial 172
Role of positron emission tomography in indolent non Hodgkin lymphomas 172
Clinical and molecular characteristics of lymphoplasmacytic lymphoma not associated with an IgM monoclonal protein: A multicentric study of the Rete Ematologica Lombarda (REL) network 171
Characterization of oncogene dysregulation in multiple myeloma by combined FISH and DNA microarray analyses 170
IGHV gene analysis in chronic lymphocytic leukemia 170
Integrating clinical, morphological, and molecular data to assess prognosis in patients with primary myelofibrosis at diagnosis : a practical approach 170
Repetitive DNA hypomethylation in multiple myeloma 169
Lamivudine prophylaxis prevents hepatitis B virus reactivation in anti-HBc positive patients under rituximab for non-Hodgkin lymphoma 168
Frequency and clinical relevance of coding and noncoding NOTCH1 mutations in early stage Binet A chronic lymphocytic leukemia patients 168
Cytogenetic study in primary myelofibrosis at diagnosis: Clinical and histological association and impact on survival according to WHO 2017 classification in an Italian multicenter series 168
Front-line chemo-immunotherapy RITUXIMAB –FC + RITUXIMAB maintenance in patients with untreated advanced stage non follicular lymphoma (INFL) : update of a prospective study of the intergruppo italiano linfomi and Roche (ML18324) 167
Molecular classification of Multiple Myeloma : a distinct trascriptional profile characterizes patients expressing CCND1 and negative for 14q32 translocation 167
IgG and IgA Monoclonal Gammopathies of Undetermined Significance (MGUS) at Low Risk of Evolution : Proposal and Validation of a Prognostic Scoring System 167
A brief rituximab, bendamustine, mitoxantrone (R-BM) induction followed by rituximab consolidation in elderly patients with advanced follicular lymphoma: a phase II study by the Fondazione Italiana Linfomi (FIL) 167
Phase III randomized trial comparing R-chop vs R-miniceop in elderly patients with diffuse large B-cell lymphoma (B-DLCL) prospectively selected by a multidimensional evalutation scale 165
Genomic lesions associated with a different clinical outcome in diffuse large B-Cell lymphoma treated with R-CHOP-21 165
R-chop vs R-mini ceop in elderly patients with diffuse large B cell lymphoma : an interim report from intergruppo italiano linfomi (IIL) 164
What Is New in the Treatment of Smoldering Multiple Myeloma? 164
A multicenter retrospective clinical study of CD5/CD10-negative chronic B cell leukemias 163
Genome-wide analysis of DNA copy number in multiple myeloma using high-density SNP arrays reveals clustering patterns with distinct transcriptional profiles 162
Proposal and validation of prognostic scoring systems for IgG and IgA monoclonal gammopathies of undetermined significance 162
Distinct Metabolic Profile Associated with a Fatal Outcome in COVID-19 Patients during the Early Epidemic in Italy 162
A phase III study of double autotransplantation incorporating bortezomib-thalidomide-dexamethasone (VTD) or thalidomide-dexamethasone (TD) for multiple myeloma : superior clinical outcomes with VTD compared to TD 160
Superior complete response rate and progression-free survival after autologous transplantations with up-front velcade-thaliomide-dexamethasone compared with thalidomide dexamethasone in newly diagnosed multiple myeloma 160
Functional and multimarker analysis of T-cell chronic lymphocytic leukaemia 160
Lenalidomide, melophalan, prednisone and thalidomide (RMPT) for relapsed/refractory multiple myeloma 159
The Physiopathology of T- Cell Acute Lymphoblastic Leukemia: Focus on Molecular Aspects 158
Analysis of hiperdiploidy in Multiple Myeloma by fluorescence in situ hybridization. 156
Long term follow-up analysis of HD9601 trial comparing ABDV VS Stanford V VS moppabvcad in patients with newly diagnosed advanced stage Hodgkin lymphoma. A study from the Intergruppo Italiano Linfomi (ILL) 156
Integration of total body CT scan in the initial work-up of binet stage a CLL patients on clinical grounds : preliminary results of a prospective multicenter observational-CLL1 Gisl study 156
Analysis of alterations of oncogenes and tumor suppressor genes in chronic lymphocytic leukemia 156
The prevalence and clinical implications of c-kit expression in plasma cell myeloma 155
A phase III study of enoxaparin versus fixed low-dos warfarin versus low-dose aspirin at thromboprophylaxis for newly diagnosed multiple myeloma patients treated with thalidomide containing regimens 154
Molecular classification of multiple myeloma : a distinct transcriptional profile characterizes patients expressing CCND1 and negative for 14Q32 translocations 154
Genome-wide analysis of DNA copy number changes in multiple myeloma using high-density SNP arrays 153
Gene expression profiling of plasma cell dyscrasias reveals Multiple Myeloma molecula heterogeneity 153
Global hypomethylation of repetitive DNA elements is associated with tumor progression in multiple myeloma 152
External validation on biological basis of new prognostic index in early asymptomatic chronic lymphocytic leukemia (CLL) patients : the Gruppo italiano studio linfomi (GISL) experience 152
Incidence of cytogenetic abnormalities in newly diagnosed binet stage a CLL and relationship with prognostic biomarkers : updated results on 344 patients included in the prospective O-CLL1 Gisl study 150
The prognostic value of F-18 fluorodeoxyglucose bone marrow uptake in patients with recent diagnosis of multiple myeloma : a comparative study with Tc-99m sestamibi 150
A peculiar B-Cell subset, frequently IGVH hipermutated, is identified by a simplified immunophenotype-fish diagnostic algorithm 150
Subgroups of diffuse large B-CELL lymphoma (DLBCL) with different genomic lesions and clinical course during treatment with R-chop 149
Gene expression profiling of plasma cell dyscrasias reveals molecular patterns associated with distinct IGH translocations in multiple myeloma 149
Totale 19.329
Salva come PNG Salva come JPEG
Categoria #
all - tutte 100.212
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 100.212
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.580 0 0 0 0 0 0 0 236 477 529 217 121
2020/20214.465 224 330 404 78 377 250 279 222 574 277 1.099 351
2021/20223.558 312 132 201 127 280 207 347 172 599 272 189 720
2022/20234.297 609 380 368 474 509 897 73 252 402 48 189 96
2023/20246.962 100 218 113 156 509 312 994 938 429 952 1.122 1.119
2024/20255.051 995 1.086 817 972 440 338 304 99 0 0 0 0
Totale 42.447